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This study sought to characterize the bacterial and fungal microbiota changes
associated with Clostridium difficile infection (CDI) among inpatients with diarrhea, in
order to further explain the pathogenesis of this infection as well as to potentially guide
new CDI therapies. Twenty-four inpatients with diarrhea were enrolled, 12 of whom had
CDI. Each patient underwent stool testing for CDI prior to being treated with difficile-
directed antibiotics, when appropriate. Clinical data was obtained from the medical
record, while each stool sample underwent 16S rRNA and ITS sequencing for bacterial
and fungal elements. An analysis of microbial community structures distinct to the CDI
population was also performed. The results demonstrated no difference between the
CDI and non-CDI cohorts with respect to any previously reported CDI risk factors.
Butyrogenic bacteria were enriched in both CDI and non-CDI patients. A previously
unreported finding of increased numbers of Akkermansia muciniphila in CDI patients
was observed, an organism which degrades mucin and which therefore may provide
a selective advantage toward CDI. Fungal elements of the genus Penicillium were
predominant in CDI; these organisms produce antibacterial chemicals which may resist
recovery of healthy microbiota. The most frequent CDI microbial community networks
involved Peptostreptococcaceae and Enterococcus, with decreased population density
of Bacteroides. These results suggest that the development of CDI is associated with
microbiota changes which are consistently associated with CDI in human subjects.
These gut taxa contribute to the intestinal dysbiosis associated with C. difficile infection.
Keywords: Clostridium difficile, microbiome, bacterial, fungal, diarrhea
Abbreviations: ANOSIM, analysis of similarity; BLAST, basic local alignment search tool; CDI, Clostridium difficile
infection; CSS, cumulative sum scaling; LEfSe, Linear Discriminant Analysis effect size; NAAT, nucleic acid amplification
test; OTUs, operational taxonomic units; PCoA, principal coordinates analysis; PCR, polymerase chain reactions; tcdA, gene
for toxin A.
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INTRODUCTION
The community of indigenous microorganisms (including
bacteria, viruses, and fungal elements) which co-exist within
a host’s gastrointestinal tract is termed the gut microbiome.
Disturbances to the gut microbiota, particularly by antibiotics,
have been linked to the development of CDI (Peterfreund et al.,
2012; Theriot et al., 2014). In healthy patients, normal indigenous
microbes have been hypothesized to prevent disease states
through alleged mechanisms such as direct pathogen inhibition,
depletion of pathogen required nutrients, and stimulation of the
host immune system (Stecher and Hardt, 2011). However, the
majority of studies evaluating changes to these gut microbial
communities in the setting of CDI have either been limited
to niche human populations, such as infants or the elderly,
or they have resorted to murine models (Reeves et al., 2011;
Rea et al., 2012; Rousseau et al., 2012; Lawley and Young,
2013; Koenigsknecht et al., 2015; Miezeiewski et al., 2015).
From this relatively small body of published literature, there
is a consensus that a common feature distinguishing the CDI
patient from a healthy subject is a significant decrease in both
population diversity and density of bacterial species characterized
by a loss of frequently encountered commensal bacteria and
an overabundance of certain anaerobes (Proteobacteria; Skraban
et al., 2013; Zhang et al., 2015).
There are four elements to current microbiome studies
which limit their clinical relevance. First, a significantly under-
represented feature of most published microbiome studies relates
to an analysis of the altruistic or adversarial relationships
between bacterial community structures in the gut of the same
patient. The compositional profile of individual and aggregate
communities within the gut can shift the environment of the
large intestine toward a more or a less hospitable habitat
for pathogenic bacteria such as C. difficile through a number
of different mechanisms (such as availability of carbon and
food sources, effects on mucin and bacterial toxin production;
Perez-Cobas et al., 2014). A second factor which is often
unaccounted for in previous studies on CDI relates to the role
of fungal elements. Fungal species are a significant proportion
of the gut microbial environment but their involvement in the
development of CDI is virtually unstudied. Thirdly, there are
few studies on CDI and the microbiome which use stool from
human subjects, due to the challenges of collecting those tissue
samples and accruing cohorts with an acceptable degree of
homogeneity which would afford proper comparison. Fourthly,
studies of the microbiome in CDI require C. difficile negative
diarrheal stools as a proper control. This feature is important
since diarrhea, with or without C. difficile, is associated with
changes to the microbiota which are not present in patients
with formed stool; additionally, it is patients with diarrhea
who will be undergoing testing for CDI, and ensuring both
cohorts have similar symptoms is important for veridical
comparisons.
The current study hypothesizes that CDI as a disease state of
the gut is associated with certain bacterial and fungal community
structures which are consistent between human hosts. The aim of
this study was to compare and contrast different microbial taxa
and various microbial network co-occurrence patterns observed
among prospectively collected, human derived C. difficile positive
and negative diarrheal stool samples. It is postulated that this
information would prove valuable in better understanding the
mechanism of how previously reported changes in gut taxa lead
to CDI, as well as potentially providing targets for prevention and
treatment.
MATERIALS AND METHODS
Study Design and Specimen Collection
This prospective cohort study was conducted exclusively at the
Penn State Hershey Medical Center with approval from the
Institutional Review Board. Diarrheal stool samples collected
from hospitalized medical and surgical patients were submitted
to the Hershey Medical Center Microbiology laboratory for
C. difficile testing between June 2014 and November 2014 and
were considered for inclusion in this study. Each patient signed
an IRB approved consent form prior to their stool being collected
for use in this study. Within 12 h of stool collection, specimens
were screened for C. difficile using a NAAT designed to detect a
highly conserved region of the C. difficile tcdA. Detection of tcdA
was considered positive for CDI, while absence of detection of
tcdA was considered to be negative for CDI, mirroring clinical
practice in the senior author’s hospital. A positive or a negative
NAAT was the basis for forming the CDI and control groups.
A colleague in the clinical microbiology lab of our institution
who oversaw all testing of inpatient stool samples for CDI
would contact members of our team on a daily basis regarding
positive and negative samples. These samples awaiting retrieval
in the clinical microbiology lab would be preserved in a −80◦C
freezer. A member of our team would, as soon as possible, then
attempt to consent that patient for permission to use their stool
sample in this study, as well as receiving consent to access their
electronic medical record. Once consent was obtained, the stool
sample was moved directly from a −80◦C freezer in the clinical
microbiology lab to a −80◦C freezer in the study senior author’s
research lab. These samples were stored until all study samples
were collected, which occurred in November 2014, using this
approach so that the samples could be thawed, and processed for
sequencing during one period. Twelve patients comprised each
cohort; additionally, one patient provided a C. difficile positive
stool sample, and after successful treatment with a confirmatory
negative NAAT test, this subject’s stool was collected again after
CDI therapy for post-treatment analysis. In all, there were 13
samples in each of the two cohorts.
Inclusion criteria for both cohorts included patients 18 years
of age or older who submitted a diarrheal stool sample for CDI
testing as part of each patient’s routine clinical care. Exclusion
criteria included an age younger than 18 years, a gravid status,
the inability to provide informed consent, or the administration
of difficile-directed antibiotics prior to a stool sample being
collected. The research team was notified of candidate samples
on a daily basis, allowing for informed consent from potential
study subjects to be obtained in a timely fashion. Following the
consent process, stool samples were immediately obtained from
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the Microbiology laboratory and were stored in the laboratory of
the principal investigator (DBS) at −70◦C for use in the present
study.
PCR Amplification
DNA was extracted from approximately 0.25 g of fecal material
using the MoBio PowerfecalTM DNA Extraction Kit following
the manufacturer’s instructions (MoBio, Carlsbad, PA, USA).
Illumina iTag PCR reactions (25 µL) contained ∼5–10 ng of
template DNA and a final concentration of 1x PCR buffer, 0.8 mM
dNTP’s, 0.625 U Taq polymerase, 0.2 µM 515F forward primer
and 0.2 µM illumina 806R reverse barcoded primer, per reaction.
PCR was carried out on an MJ Research PTC-200 thermocycler
(Bio-Rad, Hercules, CA, USA). Pooled PCR products were gel
purified using a Qiagen Gel Purification Kit (Qiagen, Frederick,
MD, USA) and were quantified using a Qubit 2.0 fluorometer
(Life Technologies, Carlsbad, CA, USA). Prior to submission
for sequencing, libraries were quality checked using the 2100
Bioanalyzer DNA 1000 chip (Agilent Technologies, Santa Clara,
CA, USA).
Sequencing
Library pools were size verified using the Fragment Analyzer
CE (Advanced Analytical Technologies Inc., Ames IA, USA)
and were quantified using a Qubit high sensitivity dsDNA kit
(Life Technologies, Carlsbad, CA, USA). After dilution to a final
concentration of 1 nM containing 10% PhiX V3 library control
(Illumina, San Diego, CA, USA), the library pools were denatured
for 5 min in an equal volume of 0.1N NaOH, were further
diluted to 12 pM in HT1 buffer (Illumina) and were sequenced
using an Illumina MiSeq V2 300 cycle kit cassette with 16S
rRNA library sequencing primers set for 150 base, paired-end
reads.
Quality Filtering/OTU Picking
Sequence reads were trimmed at a length of 150 base pairs
and were quality filtered at an expected error of less than
0.5% using USEARCH v7 (Edgar, 2013). After quality filtering,
reads were analyzed using QIIME 1.9.0 (Caporaso et al., 2010,
2011). Chimeric sequences were identified using USEARCH61
(Edgar, 2010). A total of 1,372,573 sequences were retrieved after
quality filtering and chimera checking. Open reference OTUs
were picked using the USEARCH7 algorithm (Edgar, 2010),
and taxonomy assignment was performed using the Greengenes
16S rRNA gene database (13-5 release, 97%; DeSantis et al.,
2006). Clustered taxa were compiled into an OTU table. The
unrarified OTU table underwent CSS normalization for beta
diversity analysis.
ITS Library Preparation and
Bioinformatics Analysis for Fungal
Elements
ITS fungal community analysis was performed using the ITS1-F
and barcoded ITS2 primers as described in Bellemain et al.
(2010). Illumina iTag (PCR were performed at a total volume of
25 µL for each sample and contained final concentrations of 1X
PCR buffer, 0.8 mM dNTPs, 0.625 U Taq, 0.2 µM ITS1-F forward
primer, 0.2 µM reverse barcoded ITS2 primer and ∼10 ng
of template DNA per reaction. PCR was carried out on a MJ
Research PTC-200 thermocycler, and PCR products were pooled
and purified as described for 16S rRNA gene libraries. OTUs were
picked de novo using the UPARSE algorithm with singleton reads
discarded as recommended by Edgar (2013). The OTUs in the
data set were compared against the fungal ITS UNITE database
using the BLAST.
Microbial Community Analysis
Principal coordinates analysis plots and ANOSIM tests for
significance were calculated using a weighted UniFrac distance
matrix generated from a CSS normalized OTU table within Qiime
1.9.0. The non-parametric Kruskal–Wallis test for significance
was used to identify enriched taxa within control and CDI
patients. Differences were considered to be significant at an
alpha of 0.01. Relative abundance plots were produced from a
CSS normalized OTU table (Paulson et al., 2013). LEfSe was
also used to identify taxonomic biomarkers between control
and CDI patients (Segata et al., 2011). Genus-level relative
abundances were multiplied by one million and were formatted
as described in Segata et al. (2011). Comparisons were made
with “Status” (control or CDI) as the main categorical variable.
Alpha levels of 0.10 were used for the Kruskal–Wallis tests,
and Linear Discriminant Analysis scores for the enriched taxa
within each class were plotted. Features were plotted on a
logarithmic scale according to the experimental group to which
they were significantly associated. LEfse explicitly requires all
pairwise comparisons to reject the null hypothesis for detecting
the biomarker taxa; thus, no multiple testing corrections were
needed (Segata et al., 2011). Alpha diversity indices, including
Chao1, Heip’s evenness, Observed Species, and PD Whole
Tree, were generated from an unrarified OTU table with a
max sampling depth of 1900, a step size of 190, and with
25 iterations at each step. Core microbiome analyses were
conducted on an unrarified OTU table within qiime-1.9.0.
Network plots were generated within Cytoscape 3.2.0 from
a filtered OTU table rarified at a sequencing depth of 3218
within Qiime1.9.0. Only OTUs identified at the species level
were kept for network analysis, all remaining taxa were filtered
within Qiime. The Cytoscape style Biopax was utilized for data
visualization.
A co-occurrence network was created within the Cytoscape
plugin Conet from an unrarified OTU table containing bacterial
abundance data from twelve CDI patients (Faust et al., 2012).
All taxa unassigned at the kingdom taxonomic ranking were
discarded. Spearman’s correlations between taxa abundances
were calculated, and only strong correlations (Spearman’s
rho > ±0.8) were included in the network. Minimum OTU
occurrence was set to 10, discarding all OTUs not observed 10
times within each sample.
Sample Size Calculation
While there is a relative dearth of previous publications which
could guide a sample size estimate for a study focused on
inpatients with diarrhea, assuming a richness of 1,000 OTUs at a
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power of 0.8, 10 subjects per cohort would require a minimum
change in abundance of 2.5-fold for significance. The present
study surpasses this requirement.
RESULTS
Description of Study Population
The stool samples of twelve patients with CDI and twelve patients
without CDI were used in this study. Table 1 outlines the clinical
characteristics of these patients. All patients enrolled in this
study had diarrheal stools, and the two cohorts demonstrated
no significant differences in terms of the selected clinical
characteristics. There was no disparity in any risk factor for
CDI, or for other causes of diarrhea, identified between the
cohorts.
Assessment of Alpha and Beta Diversity
of Bacterial Microbiota
When comparing observed richness and evenness in control
subjects versus CDI patients, two-sample non-parametric t-tests
demonstrated no significant difference between the two groups
(richness: P = 0.224; evenness: P = 0.760). Beta diversity,
however, did reveal differences in the bacterial community
structure between the control and CDI cohorts as demonstrated
by the distinct clustering observed between the two cohorts on
PCoA (Figure 1). Analysis of similarities confirmed that this
clustering was significant (P= 0.004), though these differences in
bacterial community structures did not vary significantly based
on either age (P = 0.644) or sex (P = 0.603).
TABLE 1 | Patient characteristics.
Variable CDI (n = 12) Diarrheal
control
(n = 12)
P-value
Age, mean [SD] 55.5 ± 20.5 51.2 ± 16.6 NS
Sex NS
Female 5 (41.7) 7 (58.3)
Male 7 (58.3) 5 (41.7)
Body mass index (kg/m2), mean [SD] 29.3 ± 7.8 34.3 ± 13.3 NS
Hospitalized within last 3 months 8 (66.7) 7 (58.3) NS
Surgery within last 6 months 3 (25) 3 (25) NS
Antibiotic use within last 3 months 6 (50) 7 (58.3) NS
Amoxicillin/clavulanate 1 (8.3) 0
Cephalosporin 4 (33.3) 3 (25)
Fluoroquinolone 2 (16.7) 2 (16.7)
Intravenous vancomycin 1 (8.3) 3 (25)
Trimethoprim– sulfamethoxazole 0 3 (25)
Proton pump inhibitor use within last
3 months
9 (75) 8 (66.7) NS
History of Clostridium difficile infection 3 (25) 0 NS
History of inflammatory bowel disease 1 (8.3) 1 (8.3) NS
Length of hospital stay prior to specimen
collection (days), mean [SD]
5 ± 4 3 ± 2 NS
Values within parentheses represent percentages unless indicated otherwise.
Fecal samples from both cohorts were dominated by
Lachnospiraceae, Bacteroidaceae, and Ruminococcaceae
families (Figure 2). Non-parametric Kruskal–Wallis tests
identified specific taxa that were enriched in either of
the cohorts. Interestingly, three different OTUs from the
Peptostreptococcaceae matching closely (>97%) to C. difficile
strain 630 were significantly enriched (P < 0.005) in CDI fecal
samples. In addition, two OTUs, Akkermansia muciniphila and
an unknown Enterobacteriaceae, were also more abundant in
CDI individuals. A plethora of taxa were significantly enriched in
the control cohort, including members of the Bacteroidales and
Clostridales groups.
Fewer OTUs were shared among CDI individuals as compared
to control patients, suggesting several members of the core
microbiome are lacking in CDI, and further analysis of the
prevalence and abundance of the specific bacterial families within
the study cohorts demonstrated that Enterobacteriaceae and
Peptostreptococcaceae were more abundant in CDI individuals
as compared to non-CDI individuals (Figure 3). In contrast,
Bacteroidales family S24-7 was enriched in non-CDI individuals.
Figure 4 provides a Venn diagram breakdown demonstrating
the distinct and shared OTUs between CDI and non-CDI
states.
Fungal Community Results
Of the nine OTUs found to be significantly enriched in
the infected cohort, eight unique OTUs were matched to
unknown fungal taxa labeled as “uncultured fungus,” with these
data suggesting that a defined fungal community of currently
unknown phylogenetic origin comprised a significant portion of
the fungal community within patients affected with CDI. The
only enriched taxa within the CDI cohort that was successfully
mapped to the fungal database belonged to the Penicillium genus.
In summary, a small number of commonly detected species were
detected in non-CDI subjects, while a larger number of rare taxa
were pervasive in the CDI group.
Community Structure and
Co-Occurrence Analysis
The co-occurrence network (Figure 5) revealed strong
correlations between bacterial taxa (communities) within
the fecal microbiome of CDI patients. Taxa of interest within
the infected cohort included unclassified Peptostreptococcaceae,
which matched C. difficile strain 630 when BLAST searched
(100% query), Enterococcus and unclassified Clostridiales.
Interactions with Peptostreptococcaceae revealed strong negative
correlations with three different Bacteroides OTUs, including
an OTU matching to Bacteroides fragilis. Enterococcus was
also negatively correlated to the same Bacteroides strains, as
well as Wolbachia, Methylophilaceae, and Methylobacterium
adhaesivum. Clostridiales OTUs had strong positive correlations
with Parabacteroides, Bacteroides, and Lachnospiraceae.
Antibiotic Effect on Community Structure
A single patient from the CDI cohort underwent successful
treatment with 10 days of antibiotics (metronidazole). A second
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FIGURE 1 | Principal Coordinates Analysis in non-CDI and CDI fecal samples. Weighted UniFrac distance matrices were generated from a filtered OTU table
that underwent CSS normalization. Control samples (n = 13) are displayed in blue, while CDI samples are in red (n = 13). Distinct clustering can be observed
between bacterial communities of these two groups. Sample S1 (no antibiotics) and S1A (antibiotics) are fecal samples from the same control individual. Sample
CD3 (no antibiotics) and CD3A (antibiotics) are fecal samples from the same individual with CDI.
FIGURE 2 | Relative abundance of bacterial families in CDI and non-CDI individuals. The relative abundance of the top 10 most abundant bacterial families
for CDI (n = 13) and control (n = 13) fecal samples. Relative abundance of taxa was determined based on the relative abundance of 16S rRNA gene sequences
assigned to a given bacterial family using the Greengenes database.
stool sample was collected 12 days after the conclusion of
CDI antibiotic therapy and was confirmed to be negative
for C. difficile based on nucleic acid amplification testing for
tcdA. The microbial community following successful treatment
for CDI demonstrated a shift toward the same microbial
community structures common among the non-CDI cohort. The
greatest shifts observed were a fourfold increase in unclassified
Acetobacteraceae in response to antibiotic intervention, and
a fourfold decrease in Myxococcales OM27 in response to
treatment.
A total of 6 of the 11 most abundant genera within this
treated subject observed a twofold shift in response to antibiotic
treatment. The most dramatic increases (>10%) within this
group of 11 taxa were observed within the Bacteroidales S24-
7 and Clostridiales. The Ruminococcaceae and Lachnospiraceae
presented the greatest decrease (>7%) in response to antibiotics.
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FIGURE 3 | Prevalence of specific bacterial families in CDI and non-CDI cohorts. The circos plot displays relative abundance of bacterial orders within
control and CDI samples. Plots were generated from a CSS normalized OTU table with all singletons removed. The abundance of each order is directly proportional
to the width of each ribbon connecting bacterial taxa to its respective sample. Each bacterial family is assigned a specific color. The outer ring represents the
cumulative percent of 16S sequences assigned to a given family from each sample, while the inner circle represent the number of 16S rRNA sequences assigned to
a given taxa in a given sample.
DISCUSSION
The results of this study can be summarized as follows. In
contradistinction (Antharam et al., 2013) to several previous
publications, our patient population was found to have a
relatively rich abundance of butyrogenic bacteria (such as
Lachnospiraceae and Ruminococcaceae) in both the CDI and
non-CDI cohorts, though the non-CDI cohort was more
replete with the organisms. CDI patients were noted to have a
predominance of anaerobes of the Peptostreptococcaceae family,
with a relative depletion of anaerobes of the Bacteroidales
and Clostridiales groups. A previously unreported finding of
increased numbers of Akkermansia muciniphila in CDI patients
was observed, as was an increase in several unknown species
Frontiers in Microbiology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 789
fmicb-07-00789 May 24, 2016 Time: 17:14 # 7
Sangster et al. CDI Microbial Community Structures
FIGURE 4 | Venn diagram demonstrating distinct and shared OTUs between non-CDI and CDI states.
FIGURE 5 | Co-occurrence network plot of bacterial taxa within the fecal microbiome of CDI patients. The co-occurrence network plot generated within
the Cytoscape plugin Conet reveals strong positive (Spearman’s rho > 0.8) and strong negative (Spearman’s rho < −0.8) correlations between OTUs identified
within 13 CDI stool samples. Eighteen unique OTUs (indicated by rectangular nodes) possessing strong correlations with one another are shown. The 16S rRNA
sequence of the Peptostreptococcaceae node highlighted in red matched Clostridium difficile strain 630 (query cover = 100%) when BLAST searched. Additional
potential pathogenic OTUs are shown in orange, including Enterococcus and an unclassified Clostridiales. Edges connecting nodes highlighted in green are
indicative of a strong positive correlation, whereas edges highlighted in red are indicative of a strong negative correlation.
of Enterobacteriaceae. Fungal OTUs have not been previously
reported in the CDI population, and this study identified fungal
elements of the genus Penicillium as a predominant feature of
CDI. Within CDI patients, the microbial community networks
most frequently encountered were Peptostreptococcaceae and
Enterococcus, to the exclusion of Bacteroides. Lastly, following
successful treatment of a CDI patient, comparison of microbial
communities before and after treatment reveal a shift toward
greater numbers of Bacteroides and butyrogenic bacteria, similar
to the microbial communities encountered in non-CDI patients,
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providing a causal description for the microbiota changes
associated with successful antibiotic treatment for CDI.
There are several interesting observations from this study.
One important reflection from a review of Table 1 reveals an
equal distribution of frequently cited clinical risk factors for
CDI (Thibault et al., 1991; Bignardi, 1998; Hegarty et al., 2014;
Regnault et al., 2014) between both the infected and uninfected
cohorts. In this study of inpatients with diarrhea, the use of,
and type of antibiotic, use of proton pump inhibitors, previous
diagnosis of CDI, diagnosis of inflammatory bowel disease and
length of stay did not significantly differ between CDI and non-
CDI patients with diarrhea. While these clinical variables are
associated risk factors for CDI, their discriminatory power for
inpatient populations may be limited given the large number of
diarrheal patients with and without CDI who share these factors.
This observation may indicate that diarrhea among inpatients
should probably reflex to CDI testing, as any attempt at stratifying
a patient’s risk for CDI based on clinical factors lacks specificity
to reliably dispense with stool testing.
There have been virtually no studies investigating shifts in
fungal microbiota in diarrheal patients, with or without CDI.
The present study demonstrated that in CDI patients, OTUs
associated with the genus Penicillium were prominent. This
fungus is associated with diarrhea in immunocompromised
patients (Leung et al., 1996). Studies assessing the effect of
antibiotics on the hamster gut microbiome, such as in the
setting of clindamycin used to induce CDI, have reported that
Penicillium was a predominant fungal element (Peterfreund et al.,
2012). The present study is the first to describe this same
association in human subjects, and the Penicillium genus may be
a potential biomarker for CDI infection in humans with diarrheal
illnesses. Interestingly, Penicillium is useful in environmental
microbiology due to its utility in bioremediation, as it produces
enzymes which degrade a number of xenobiotic compounds,
all of which can prevent bacterial colonization and survival
(Leitao, 2009). This effect of Penicillium on ambient bacteria
could represent a causal mechanism by which this fungus may,
in conjunction with disturbances to the normal microbiota, help
to further promote intestinal dysbiosis as well as resisting shifts
back toward healthy gut ecologies.
The predominance of Akkermansia muciniphila in CDI
patients is a novel observation in human subjects. Murine models
have noted that changes to the normal thickness and constitution
of colonic mucus, especially within the right colon, have effects
on colonization of the large intestine with normal microbiota
(Semenyuk et al., 2015). A normal mucus layer is essential to the
establishment and preservation of non-pathogenic gut associated
communities commensurate with normal health. A. muciniphila
is a well-known mucin-degrader, which may provide a selective
advantage to C. difficile in establishing a predominant population
within the gut (Derrien et al., 2004, 2008; van Passel et al., 2011).
It has recently been reported that C. difficile can itself reduce
the production of mucin, while also altering the composition of
mucus to allow additional C. difficile an advantage in adhering
to the altered mucus as opposed to other beneficial organisms
(Engevik et al., 2015). The co-occurrence of A. muciniphila in
CDI patients may be a result of initial shifts toward the CDI
disease state, with an increase in pathogenic bacteria such as
A. muciniphila leading to the entrenchment of pathogenic gut
communities via changes to colonic mucus. This may be one of
several potential reasons that C. difficile infection is so resistant
to treatment, due to the co-emergence of other bacteria that are
not susceptible to difficile-directed antibiotics and that promote a
gut environment with barriers to reverting to a healthy ecology.
The strong negative correlation between C. difficile and
Bacteroides in this study is of interest, as the Bacteroides
are abundant and mutualistic members of the human gut
microbiome, being involved in key metabolic processes involved
in normal intestinal health, including carbohydrate fermentation
and polysaccharide production (Wexler, 2007). One reason
Bacteroides excel at dominating the gut microbiota relates to their
ability to modulate surface polysaccharides in an effort at evading
host immune systems (Wexler, 2007). Furthermore, B. fragilis has
been shown to promote growth of gut-associated lymphoid tissue
by producing polysaccharides that can activate CD4+ T cells
which assist in directing lymphocytes to sites of infection (Round
and Mazmanian, 2009). Rousseau et al. (2011) observed a similar
trend in a cohort of infants, where a low Firmicutes to Bacteroides
ratio and an increase in facultative anaerobes was associated with
an observed increase in colonization by C. difficile. In this study,
a strong positive correlation with unclassified Clostridiales was
found. Our data suggest that C. difficile may actually repress
the growth of commensal bacteria such as Bacteroides based on
community modeling in the CDI cohort.
Analysis of the microbiota community of a CDI positive
individual following 10 days of difficile-directed antibiotic
therapy with metronidazole revealed the selective enrichment
of Bacteroidales S24-7 within the post-antibiotic stool sample.
Interestingly, this order of bacteria are known to produce
butyrate, a short chain fatty acid that has been shown to
promote colonic barrier strength at appropriate concentrations
by increasing mucin production, decreasing colonic permeability,
and thereby reducing the susceptibility of the colon to infections
(Hatayama et al., 2007). In prior studies, the relative depletion
of butyrogenic bacteria has been described to play a key
role in the conversion of the intestinal microenvironment to
one that favors the germination and growth of C. difficile
(Antharam et al., 2013; Zhang et al., 2015; Gu et al., 2016).
The predominance of Bacteroidales may be a biomarker
signaling a shift in the gut environment that coincides with
eradication of C. difficile infection, and the effect of butyrate
on promoting gut health may be one of the mechanisms for
this effect. It should be noted that our data on microbiota
changes in CDI patients after antibiotic therapy is very
limited by the current study analyzing only one sample
from one patient following successful antibiotic therapy for
CDI.
The present study is limited by being performed at a single
medical center. Additionally, although our number of subjects
surpasses the minimum necessary based on our sample size
calculations, the present study included a smaller number of
subjects due to the expense of a study of this type. Since the
current study population was limited to inpatients, many of the
study subjects were placed on antibiotics for various reasons,
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and the use of antibiotics can significantly affect the composition
of gut microbiota. The current study population, as described
in Table 1, harbored no statistically significant differences in
any of the indices listed in this table, including the incidence
of antibiotic use as well as the type of antibiotic used. In
an effort to have homogenous cohorts, we limited our study
to those with diarrhea, and as Table 1 demonstrates, these
groups of patients were quite similar in terms of demographics,
chronic health conditions and CDI risk factors. Secondly, this
is not the first study to describe changes in OTUs based on
16S rRNA sequencing. Our study attempted to go beyond this
by including information on fungal elements, and by focusing
on how communities of bacterial and fungal microbiota differ
between CDI and non-CDI diarrheal states. This, coupled with
our focus on inpatients with diarrhea, provide not only novelty,
but a study that speaks to the patients who most frequently
undergo CDI testing.
CONCLUSION
Clostridium difficile infection is associated with reproducible
and consistent changes in the microbiome, including the rise
of pathogenic anaerobic organisms (Peptostreptococcaceae and
Enterococcus), mucin degrading bacteria (A. muciniphila) and a
predominant fungal element (Penicillium). These microbes may
exert a synergistic effect, providing C. difficile with a selective
advantage by creating multiple barriers toward reversal of the
intestinal dysbiosis associated with the CDI disease state. These
gut taxa contribute to the intestinal dysbiosis associated with
C. difficile infection.
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